Digital Digital biomarkers: Redefining respiratory care Respiratory diseases, common examples of which include asthma and chronic obstructive pulmonary disease (COPD), affect one in five people in the UK.1 The economic burden of these
Digital Generative AI in pharma: Moving beyond hype and into widespr... Generative AI (GenAI) has rapidly pushed its way to the forefront of tech innovation.
Digital ECG data and AI will fuel pharma’s next drug development and... Discover how the integration of ECG data and AI is transforming the pharmaceutical industry, revolutionising drug development and commercialisation.
Digital Why it's vital to minimise waste to make a more sustainable ... Incorporating environmentally friendly practices has become everyone's responsibility.
Digital Sponsored Decoding prescriber behaviour: Insights from PurpleLab Launching a new pharmaceutical product is a high-stakes endeavour.
Digital Sponsored Reimagining digital health partnerships: A practical guide f... With billions invested and digital health initiatives on the rise, why do so few pharma-tech partnerships achieve lasting success?
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.